A reader for the BowTied ecosystem
Every BowTied Substack and blog, tracked in one place. New posts surface here as soon as they're published.
Welcome Avatar! It looks like things are playing out roughly as expected. Right now we’re surprised the sell off wasn’t more severe but the next few weeks will give us an indication of how much investors believe Warsh. He…
Your price is not a number. It is the first story your store tells. Here is how to tell it correctly. Most store owners set prices the same way. They find the supplier cost. They calculate the margin they need. They check what…
A lot of people are blackpilling with dating rn I had a girl call me last night and say she’s done with dating She isn’t Most women are not They have been discussing boys since they were girls Most guys have never been into women…
Welcome Avatar! In the tradfi world, when a company goes bust you try to do almost anything to restructure its obligations and keep it operating. That’s why you may see headlines about big companies going “bankrupt” only to seem…
Welcome Avatar! August was a bit of a strange month. Inflation hit its lowest level of the year, reserves reached a record high, the peso remained stagnant, and yet the real economy plummeted. Then, the government shifted the…
If you’re dealing with acne, there’s a good chance you’ve come across PanOxyl. The brand has two popular benzoyl peroxide cleansers, one with 4% and another with 10%, and choosing between them isn’t always as straightforward as…
Welcome, aspiring polyglot! As we age, it is very easy to slow down or even stop learning altogether. After all, if you spent the first twenty or thirty years of your life learning, surely by your forties it is time to use the…
Welcome Avatar! Know that guy who seems to hit the jackpot no matter what? Starts something new, seems like it’ll fail and then gets enormous? The guy who falls backward into the right social groups? The dude who somehow lands…
A game related post after a while, but they are worth writing because every time I see my Google Analytics, I find a lot of young men on the dating related posts. First of all, make sure you’ve downloaded and read No-BS Casual…
"Whatever you can do, or dream you can, begin it. Boldness has genius, power and magic in it." - Goethe All the mental suffering from any course of action comes from the part where you’re waffling back and forth debating with…
Capricor Therapeutics ($CAPR) is a catalyst-driven setup centered on the expected November 22, 2026 FDA decision for deramiocel in Duchenne muscular dystrophy. The date should be treated cautiously because secondary reporting…
The Death of the Nightlife Era I recently stopped doing alcohol dates. This was a combination of me focusing more on my health, going to the gym more, along with a gradual decrease in drinking and “nightlife” over the years. In…
Welcome Avatar! Despite all the ups and downs we’re staying consistent with what we think is happening under the hood. Majority of people are heavily over-indexed to growth. This isn’t a bad thing if your holding period is…
Hey guys, I used this guide that I talked about in my podcast to grow my Twitter account This is my telegram group here We have about 100 guys Good way to meet people in your city -BTSC
Welcome Avatar! To the latest edition of DeFi Roundup, where we save you time by filtering the market and separating the signal from the noise. You don’t have to spend all week scrolling Crypto Twitter to stay current. Market…
Hello Avatar! Welcome back for another week of biotech analysis. Today is Sunday, which means this is our Building Biotech newsletter that is focused on discussing biopharma strategy topics. This week we dive into one of the most…
Hello Avatar! Welcome to the BowtiedBiotech podcast, where science meets business! If you're fascinated by breakthrough biotech, bold innovations, and the business behind the science, you're in the right place. Each week, we dive…
Welcome Avatar! As promised have another half post update after the inflation print. Looks like it lines up for the same either 1) we get the pull back and print to up only or 2) they give up at the Fed and decide that they…
You already know that LLMs are just an aggregation of what other people are saying throughout the internet. Some of those are things you can influence, others you can’t. Press releases are firmly in the “can” category. Once you…
Hello Avatar! Another week of biotech news is in the history books. We are proud to bring you the latest edition of our weekly biotech news fix. The content is designed to be consumed as a quick scroll to bring readers up to…
Welcome Avatar! At five o’clock in the morning on February 1, 1931, a man dressed in a brand-new, spotless blue mechanic’s jumpsuit entered the courtyard of the Palermo National Penitentiary. Today, that site is known as Las…
Welcome Avatar! The advent of blockchains brought a level of transparency the financial markets have yet to see. However, they also provide pseudonymity and global, uninterrupted 24/7 accessibility. The recent launch of $LAPTOP…
Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary, as always on Thursday, focuses on the general market update. This week confirmed the playbook. Biotech can rally and capital can return quickly, but…
1) Fear of embarrassment is stupid. No one cares about you enough to remember your embarrassments. People are simply too preoccupied with themselves. This leaves you free to experiment and fail. You should take more risks and be…
Welcome Avatar! We’ve got a half post here. We’re going to do another half post on Friday after all the inflation data comes out. Due to labor day the scheduling all got moved around and it doesn’t make sense to ignore it as the…
Hello Avatar! Welcome to the BowtiedBiotech podcast, where science meets business! If you're fascinated by breakthrough biotech, bold innovations, and the business behind the science, you're in the right place. Each week, we dive…
Welcome, aspiring polyglot! Recently I was talking to my wife about the biggest changes in our life since having a baby and what it really boiled down to is that a lot of things are less convenient than before. Rather, many of…
I haven’t met many people who started a website who hadn’t been thinking about it for a long time beforehand. They fantasize about how it’s going to go. They can see the success in their mind. They can literally feel the…
Welcome Avatar! The most degenerate part of crypto just had its most active week since the launch of the TRUMP memecoin in 2025. You don’t need to run to buy a memecoin but you do need recognize that the trenches are a useful…
If you have combination skin, putting together a routine can be a little tricky. A product might feel great on one part of your face and wrong somewhere else. That doesn’t mean you need a complicated routine or a separate product…
Kazia Therapeutics ($KZIA) is a catalyst-driven setup centered on additional 2026 clinical efficacy and biomarker data from the ongoing Phase 1b study of paxalisib combinations in advanced breast cancer. This is not primarily a…
Welcome Avatar! If you found this website, we can assure you that a large percentage will heavily over-shoot their net worth targets. Not only will they overshoot it but they will realize the original target was higher than they…
In 2023, “prompt engineer” briefly looked like it might become a real profession. Anthropic advertised a Prompt Engineer and Librarian role paying between $175,000 and $335,000 per year . The job involved figuring out the best…
Welcome Avatar! As many of you know, every single investment, business idea and performance jump comes in huge waves. You have to survive the period of nothingness to get the step function later on. Tesla is no different since…
Welcome Avatar! It’s now time for our bi-weekly Q&A! We’ll be taking your questions on everything DeFi - technology, security, protocols, airdrops/farming, app tokens, and “how-to”. Please aim to get your questions in within 48…
Hello Avatar! Welcome back for another week of biotech analysis. Today is Sunday, which means this is our Building Biotech newsletter that is focused on discussing biopharma strategy topics. This week we dive into the next…